
Strontium ranelate improves radiological and clinical outcome in patients with knee OA

Strontium ranelate improves radiological and clinical outcome in patients with knee OA
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Ann Rheum Dis. 2013 Feb;72(2):179-86. doi: 10.1136/annrheumdis-2012-202231. Epub 2012 Nov 1Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
OE EXCLUSIVE
Dr. Reginster discusses strontium ranelate effect the on radiological and clinical progression of knee osteoarthritis
Synopsis
1683 patients were randomized to assess the effect of strontium ranelate on radiological and clinical progression of knee osteoarthritis (OA). Patients received either strontium ranelate 1 g/day, 2 g/day, or placebo and were assessed over 3 years. Results revealed that treatment with strontium ranelate (1 and 2 g/day) was associated with a significant effect on structure in knee OA patients. Treat...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.